PMID: 6166356May 1, 1981Paper

Nucleic acids and protein in brains and cerebella of rats transplacentally exposed to ethylnitrosourea

Brain Research Bulletin
I S Zagon, P J McLaughlin

Abstract

Female rats were injected (IP) with either 15, 60, 100, or 150 mg/kg N-ethyl-N-nitrosourea (ENU) on gestation day 18. The neurochemical development of the whole brain and the cerebellum was studied in 21- and 60-day old offspring; pups from mothers subjected to 150 mg/kg were examined only at 21 days. Brain weights were significantly reduced in all ENU-exposed groups at 21 days, and the 60 mg/kg group at 60 days. Whole brain DNA and protein concentrations of most ENU groups were elevated at 21 days and RNA content and RNA/DNA ratios were subnormal. Deficits in whole brain DNA content were observed in all ENU groups on day 60. Cerebellar weight was reduced in the 60 and 150 mg/kg groups on day 21 and in the 100 mg/Kg group on day 60. At 21 days, reductions in cerebellar DNA and RNA concentrations and contents were often recorded in several ENU groups. Cerebellar DNA concentration and content of the 60 and 100 mg/kg groups remained subnormal at 60 days of age. In general, a dose-response effect was evident in the number and magnitude of neurochemical alterations produced by ENU. These data suggest that transplacental exposure to ENU, a potent neurotropic carcinogen, affects the biochemical maturation of the brain.

References

May 3, 1976·Zeitschrift Für Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology·D A Bosch, E J Ebels
Aug 1, 1979·Toxicology·E Johansson-Brittebo, H Tjälve
Dec 1, 1978·Ecotoxicology and Environmental Safety·E J Olajos, F Coulston
Mar 1, 1975·Toxicology and Applied Pharmacology·G N Wogan, S R Tannenbaum
Jan 1, 1975·Experimental Neurology·I S Zagon
May 17, 1974·Nature·D SchubertB L Brandt
Jan 1, 1972·Zeitschrift Für Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology·D A BoschE J Ebels
Jun 19, 1973·Zeitschrift Für Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology·D A BoschE J Ebels
Oct 1, 1974·Journal of Neuropathology and Experimental Neurology·H M CraviotoJ F Ransohoff
Jun 1, 1974·Teratology·M J PfaffenrothJ P McAllister
Sep 1, 1969·Pediatric Research·I Fish, M Winick
Jan 6, 1970·Brain Research·J Dobbing, J Sands
Jul 1, 1966·The Journal of Nutrition·M Winick, A Noble
Jul 1, 1964·Journal of Neurochemistry·S ZAMENHOFP J ZAMENHOF

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.